drugset
drugset / Trial / NCT02481193

Effects of Cisatracurium on Succinylcholine-induced Fasciculations and Myalgia

NCT02481193 ↗

Phase 3 Completed 90 enrolled Yangzhou No.1 People's Hospital
RandomizedParallel-groupQuadruple-blindPrevention

Summary

The purpose of this study is to investigate the effects of different doses of cisatracurium pretreatment on succinylcholine-induced fasciculations and postoperative myalgia.

Timeline

Start
2013-03
Primary completion
2014-01
Completion
2014-01

Drugs

EvaluationDrugModalityDoseRoute
Subject Cisatracurium Small molecule 0.005 mg/kg —
Subject Cisatracurium Small molecule 0.01 mg/kg —
Subject Cisatracurium Small molecule 0.02 mg/kg —

Indications

No indication recorded.